Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome.

doi:10.1016/0022-4804(90)90172-X

Paper

Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome.

Published Dec 1, 1990 · W. Richards, R. Geer, T. O'dorisio

The Journal of surgical research

Q1 SJR score

36

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Study Snapshot

Octreotide acetate effectively treats dumping syndrome by inducing fasting small bowel motility and reducing postprandial fed motility duration and vigor.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome.

Sign up to use Study Snapshot

References

Citations

Dumping syndrome: Update on pathophysiology, diagnosis, and management.

Dumping syndrome is a well-defined but under-diagnosed complication of upper gastrointestinal surgeries, with initial treatment focusing on diet and meal viscosity enhancers, and somatostatin analogues for refractory cases.

Dumping Syndrome: Pragmatic Treatment Options and Experimental Approaches for Improving Clinical Outcomes

Dumping syndrome can be effectively managed with dietary adjustments, acarbose, and somatostatin analogues, but refractory cases require last-resort treatments.

Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update

Octreotide is the recommended drug for managing nausea and vomiting in non-operable malignant bowel obstruction, with randomized trials needed to clarify the effectiveness of ranitidine and antiemetic choices.

International consensus on the diagnosis and management of dumping syndrome

Dumping syndrome is a common complication of gastric and oesophageal surgery, and dietary adjustments and acarbose are effective first treatments.

Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management

Dumping syndrome, a common complication of esophageal, gastric, or bariatric surgery, causes gastrointestinal and vasomotor symptoms, and requires clinical recommendations for diagnosis and management.

Postoperative problems 2011: fundoplication and obesity surgery.

Antireflux surgery can cause dysphagia, gas bloat syndrome, recurrent GERD symptoms, and dyspeptic symptoms, while obesity surgery can cause dumping syndrome and esophageal dysmotility.

Gastric motility physiology and surgical intervention.

Disordered gastric motility is primarily managed with dietary modification and pharmacotherapy, with minimally invasive diagnostic and therapeutic modalities promising new treatment options.

Pathophysiology, diagnosis and management of postoperative dumping syndrome

Dumping syndrome is a common complication of esophageal, gastric, or bariatric surgery, and can be effectively managed with dietary measures, somatostatin analogs, and slow-release preparations.